Cigna Investments Inc. New Reduces Holdings in The Procter & Gamble Company (NYSE:PG)

Cigna Investments Inc. New lessened its holdings in The Procter & Gamble Company (NYSE:PG) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,086 shares of the company’s stock after selling 214 shares during the quarter. Procter & Gamble makes up about 0.7% of Cigna Investments Inc. New’s investment portfolio, making the stock its 20th largest holding. Cigna Investments Inc. New’s holdings in Procter & Gamble were worth $4,038,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in PG. AMF Tjanstepension AB boosted its position in Procter & Gamble by 416.1% during the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the period. Retirement Planning Group LLC lifted its position in Procter & Gamble by 17.6% in the third quarter. Retirement Planning Group LLC now owns 4,640 shares of the company’s stock worth $804,000 after purchasing an additional 693 shares during the period. Redhawk Wealth Advisors Inc. lifted its holdings in shares of Procter & Gamble by 1.8% during the third quarter. Redhawk Wealth Advisors Inc. now owns 13,045 shares of the company’s stock valued at $2,259,000 after acquiring an additional 229 shares during the period. Orca Investment Management LLC increased its stake in shares of Procter & Gamble by 13.7% in the third quarter. Orca Investment Management LLC now owns 3,434 shares of the company’s stock valued at $595,000 after buying an additional 414 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its stake in shares of Procter & Gamble by 5.3% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 17,222 shares of the company’s stock valued at $2,983,000 after buying an additional 863 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In related news, insider Marc S. Pritchard sold 90,450 shares of the stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 151,097 shares of company stock worth $25,635,076 over the last ninety days. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Price Performance

NYSE PG opened at $167.45 on Tuesday. The Procter & Gamble Company has a 52 week low of $153.52 and a 52 week high of $180.43. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market cap of $392.64 billion, a price-to-earnings ratio of 26.66, a price-to-earnings-growth ratio of 3.79 and a beta of 0.45. The company has a 50-day moving average price of $167.30 and a two-hundred day moving average price of $169.43.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. The company had revenue of $21.88 billion for the quarter, compared to analyst estimates of $21.66 billion. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. Procter & Gamble’s quarterly revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.84 EPS. Analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be given a $1.0065 dividend. The ex-dividend date is Friday, January 24th. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.17%.

Analysts Set New Price Targets

A number of brokerages have issued reports on PG. Stifel Nicolaus raised their target price on Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a report on Monday, October 21st. DA Davidson reiterated a “buy” rating and set a $209.00 target price on shares of Procter & Gamble in a research report on Thursday, January 23rd. JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. Finally, UBS Group lowered their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating for the company in a report on Thursday, January 16th. Eight analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.53.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.